Key result
Higher baseline cardiomyocyte DNA damage is linked to reduced myocardial recovery following GDMT in DCM.
Why the study?
The utility of mapping for assessing cardiomyocyte DNA damage was uncertain.
Does cardiovascular magnetic resonance T1 mapping correlate with cardiomyocyte DNA damage and predict myocardial tissue recovery in patients with dilated cardiomyopathy?
Observational
Does cardiovascular magnetic resonance T1 mapping correlate with cardiomyocyte DNA damage and predict myocardial tissue recovery in patients with dilated cardiomyopathy?
Cardiovascular magnetic resonance T1 mapping may reflect early myocardial injury and DNA damage preceding fibrosis in dilated cardiomyopathy, which correlates with myocardial recovery after guideline-directed therapy.
Answers are grounded in this paper and cite their sources.
May identify recovery potential in dilated cardiomyopathy; hypothesis-generating for T1 mapping before clinical use.
BACKGROUND: mapping for assessing DNA damage is uncertain. OBJECTIVES: mapping and cardiomyocyte DNA damage in patients with dilated cardiomyopathy (DCM). METHODS: mapping. DNA damage was assessed via poly(ADP-ribose) quantification in biopsy specimens, alongside collagen volume fraction (CVF) measurement. RESULTS: for an equivalent ECV (P = 0.004). In the absence of severe fibrosis, myocardial tissue recovery following guideline-directed therapy, along with improvements in left ventricular ejection fraction and reductions in left ventricular cavities, was associated with baseline DNA damage (r = -0.49, P = 0.004) but not with CVF (r = -0.17, P = 0.38). CONCLUSIONS: relative to ECV suggests early myocardial injury preceding fibrosis in DCM, with potential implications for myocardial tissue recovery after guideline-directed therapy.
No takes yet. Share an insight, caveat, or question.
Ichikawa et al. (2025) conducted an observational in Dilated cardiomyopathy (DCM). Cardiovascular Magnetic Resonance T1 Mapping was evaluated on Myocardial tissue recovery following guideline-directed therapy (r = -0.49, p=0.004). Baseline cardiomyocyte DNA damage was significantly associated with myocardial tissue recovery following guideline-directed therapy in patients with dilated cardiomyopathy (r = -0.49, P = 0.004).
Synapse has enriched 10 related papers. Consider them for comparative context: